Find product, SKU, event, etc.

Pharmaceuticals

Research news on the pharmaceutical industry including new drugs and interventions.
  1. Scientists are advancing a promising new way to fight antibiotic-resistant infections by using viruses that specifically target and kill harmful bacteria. An international team has released the first coordinated guidelines for personalized phage therapy, offering a roadmap for safely bringing this experimental treatment into clinical practice. Early findings are encouraging, with one study reporting improvement in 77% of patients and the disappearance of targeted bacteria in 61%.
  2. Scientists have solved a decades-old mystery and uncovered a hidden immune system defense that protects healthy cells from the very inflammation meant to fight infections. The surprising discovery could lead to new approaches for treating cancer, inflammatory bowel disease, and other conditions involving excessive inflammation.
  3. Scientists at Johns Hopkins have uncovered a crucial missing link between a common gut bacterium and colorectal cancer, solving a mystery that has puzzled researchers for nearly two decades. The bacterium, Bacteroides fragilis, produces a toxin that damages the colon’s protective lining, triggers chronic inflammation, and promotes tumor formation.
  4. A major international study found that a simple blood test could help predict Alzheimer’s-related cognitive decline years before symptoms appear, with the highest-risk individuals facing a 38% chance of impairment within five years and an estimated 78% chance within 10 years. Scientists believe the discovery could pave the way for earlier intervention and future treatments designed to prevent Alzheimer’s before memory problems begin.
  5. In a surprising discovery, scientists found that certain diets associated with obesity can make cancer immunotherapy more effective in mice, challenging traditional assumptions about diet and cancer treatment. The findings suggest that the secret may lie in how food interacts with gut bacteria to strengthen the immune system's response to cancer.
  6. Scientists have discovered a bizarre bacterial defense system that works almost completely backward from anything seen before. Unlike typical bacterial immune systems that keep a deadly toxin under control until a virus attacks, this unusual mechanism waits until an infection begins before producing the DNA that switches on its lethal weapon. The infected bacterium then destroys itself, preventing the virus from multiplying and spreading to neighboring cells.
  7. Cranberry juice may offer an unexpected benefit beyond its reputation for helping prevent urinary tract infections: protecting teeth from decay. Researchers at the University of Illinois Chicago discovered that pure, unsweetened cranberry juice slowed the regrowth of dental plaque bacteria and reduced their production of acids that damage tooth enamel. The secret may lie in naturally occurring compounds called proanthocyanidins, which interfere with harmful bacteria.
  8. Researchers have discovered a small group of brain cells that prevents dangerous blood pressure swings, even when average readings appear normal. The finding reveals a hidden source of cardiovascular risk and could open the door to new treatments that protect the heart and brain.
  9. Scientists have uncovered a hidden defense mechanism in aging muscles that sacrifices strength to protect cells from damage. In mice, partially restoring a crucial molecule reversed signs of muscle wasting and prevented premature death, raising hopes for new treatments for age-related muscle decline.
  10. A surprising discovery reveals that widely used anti-inflammatory drugs may unintentionally help dangerous viruses spread through the body. Scientists found that JAK inhibitors, prescribed for rheumatoid arthritis and other inflammatory diseases, can weaken a crucial immune defense against influenza, COVID-19, and other infections. By suppressing genes that normally fight viruses, these medications may leave patients more vulnerable to infection.
  11. A simple liquid painted onto teeth in seconds can stop cavities without drilling, injections, or anesthesia, according to a major clinical trial involving young children. The inexpensive treatment could spare thousands of children painful dental procedures and surgery while paving the way for broader FDA-approved use.
  12. Missing blood pressure medication could mean losing much of its protection against heart attacks and strokes, according to an analysis of more than 91,000 people. Patients who consistently took their medication experienced an 11% reduction in major cardiovascular events, while those who missed too many doses saw little or no measurable benefit.
  13. Researchers have uncovered a surprising reason dental implant infections often resist antibiotics: the implants themselves can contribute to the problem. Bacteria corrode titanium implants, releasing microscopic particles that hijack immune cells, trigger destructive inflammation, and accelerate jawbone loss.
  14. A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation to target abnormal brain activity, with a clinical trial reporting a 52% reduction in symptoms and 68% remission. Researchers believe the technology could transform PTSD care and pave the way for more precise treatments for other mental health conditions.
  15. Researchers have uncovered a hidden immune defense capable of attacking small cell lung cancer, an extremely aggressive disease that often escapes conventional treatments. The specialized immune cells can recognize and destroy cancer cells even when tumors have disguised themselves from the immune system.
  16. Researchers analyzing nearly 150,000 Reddit posts uncovered unexpected symptom reports linked by users to unapproved versions of retatrutide, including increased appetite, sleep disturbances, and elevated heart rates. The findings differ from clinical trial results and highlight how AI could help identify potential drug safety signals that warrant further investigation.
  17. Scientists have found a promising way to protect the brain from Alzheimer’s-related damage by blocking immune cells that contribute to the destruction of neurons. In mice, the treatment preserved roughly 40% more tissue in memory centers and improved memory, even without removing harmful tau protein buildup.
  18. Researchers discovered that recurring arthritis triggered by cancer immunotherapy may be driven by immune cells that remember previous attacks and return in a more aggressive state. The findings could pave the way for treatments that prevent painful flare-ups while preserving the immune system's ability to fight cancer.
  19. Scientists have uncovered an unexpected culprit behind sleep loss in Alzheimer’s disease: overactive immune cells in the brain. By temporarily removing these cells, researchers restored more than two hours of sleep per day in mice, revealing a promising new target for treatment.
  20. Eating too much salt may do more than raise blood pressure. It could also harm memory and social behavior. In a new study, Japanese researchers discovered that a soy-derived compound called LPC70 helped protect mice from several damaging effects of a high-salt diet. Mice given the supplement had lower blood pressure, better memory, and improved social interactions compared with mice consuming excess salt alone.
  21. Researchers have uncovered three brain pathways linked to lasting improvements in people receiving deep brain stimulation for severe, treatment-resistant depression. They also discovered that patients who failed to improve after two years shared a striking pattern: insufficient stimulation of a crucial brain connection. The findings suggest that millimeters in electrode placement could make a major difference in treatment outcomes.
  22. Scientists have discovered that many common sweeteners can interfere with gut bacteria, with some combinations involving medications producing surprisingly strong effects. One sweetener mixed with a widely prescribed antidepressant reduced beneficial bacteria and microbial diversity in laboratory experiments, raising new questions about potential effects on gut health and immunity.
  23. Scientists have discovered that a potential new drug can reverse severe fatty liver disease in animal models by restoring gut health and blocking harmful substances from reaching the liver. The breakthrough could pave the way for new treatments for liver disease and potentially other serious conditions, including cardiovascular disease.
  24. Stanford scientists have developed a revolutionary microscope that reveals the hidden inner workings of living cells in real time, without the fluorescent labels that can interfere with observations. The breakthrough could provide new insights into cancer, infectious diseases, and how drugs interact with cells.
  25. USC scientists have discovered a way to create a potentially renewable supply of genetically engineered immune cells that can attack cancer and strengthen the body's natural defenses. By growing and modifying immature immune cells rather than mature ones, researchers developed a system that can continuously produce tumor-fighting cells inside the body.
  26. Ice baths, massages, compression garments, and recovery supplements promise faster muscle recovery, but research suggests their benefits are often overstated, and some techniques may even undermine long-term gains. Scientists say the most effective recovery methods are far simpler and cheaper: getting enough sleep, eating well, and giving muscles time to rebuild.
  27. Scientists have developed a model showing that gut bacteria play a surprisingly important role in how many calories we absorb, meaning food labels may not tell the full story. In a controlled study, people eating a high-fiber diet absorbed about 116 fewer calories per day than those eating a typical Western diet, without feeling hungrier.
  28. A short course of immunotherapy before surgery may offer remarkably durable protection for some patients with stage two or three bowel cancer. In the NEOPRISM-CRC trial, 32 patients with a specific genetic form of bowel cancer received pembrolizumab for up to nine weeks before surgery instead of the usual post-surgery chemotherapy. After nearly three years of follow-up, none of the patients had experienced a cancer recurrence, including those who still had small traces of disease after treatment.
  29. The FDA has approved the first drug that directly targets Alexander disease, a devastating neurological disorder affecting fewer than one in a million people. Developed through decades of research, Zanvastro showed promising results in clinical trials, stabilizing motor function and even improving movement in some patients.
  30. Eating more sugar while taking antibiotics was linked to greater disruption of the gut microbiome and increased growth of potentially harmful bacteria. Researchers say temporarily cutting back on sweets during and after antibiotic treatment could be a simple way to reduce this damage, though clinical trials are still needed.
  31. Researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain. The epilepsy drug lacosamide appears to block a protein involved in both pain signaling and cartilage destruction, helping damaged joints shift back toward repair in preclinical studies.
  32. Scientists discovered that disrupting the chemical messages bacteria use to communicate can push dental plaque toward a healthier microbial balance. The approach could lead to new treatments for gum disease that control harmful bacteria without destroying beneficial species.
  33. Scientists have found a surprising way to regrow damaged knee cartilage by blocking a protein that becomes more abundant with age. In old mice, the treatment restored naturally lost cartilage and also helped prevent osteoarthritis after ACL-like knee injuries, while human cartilage taken from knee replacement patients began producing new, functional joint cartilage after exposure to the same inhibitor.
  34. Cancer immunotherapy can lose its punch when tumor-fighting T cells become exhausted, but researchers may have found a way to keep them going longer. Scientists at Memorial Sloan Kettering Cancer Center identified a signaling molecule called MEK that can push T cells to burn through their energy while producing cancer-killing proteins. In animal and laboratory studies, blocking MEK helped the cells conserve energy, survive longer, and remain active even in the harsh environment around tumors.
  35. More than half of 16,000 apparently healthy adults had signs of atherosclerosis, with arterial plaques already detectable in about 1 in 13 people ages 18 to 29. Researchers say directly imaging the arteries could reveal hidden cardiovascular disease years or even decades before symptoms appear.
  36. A 70-year-old leukemia drug is still revealing new secrets. Researchers found that removing a protein called NUDT5 protected cells from the drug, even though simply blocking the protein had little effect. The unexpected result points to a hidden cellular role that could help explain why people respond differently to certain leukemia treatments.
  37. A large study suggests the cardiovascular benefits of GLP-1 drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound can disappear surprisingly quickly when treatment stops. After two years off the medications, patients had a 22% higher risk of heart attack, stroke, and death compared with those who stayed on them.
  38. Chronic inflammation tied to stress, lifestyle, mental health, and socioeconomic conditions may silently change the heart for years before any symptoms appear. People with the highest inflammation levels faced a 43% greater risk of heart attack and stroke, raising hopes that earlier testing and anti-inflammatory treatments could help prevent serious heart disease.
  39. Scientists have identified the genetic cause behind the mysterious AnWj blood group antigen, solving a puzzle that began in 1972 and establishing a new blood group system called MAL. The discovery could make it much easier to find extremely rare AnWj-negative patients and donors and protect them from potentially dangerous transfusion reactions.
  40. Newer blood thinners may do more than prevent strokes in people with Alzheimer’s disease and atrial fibrillation. Researchers found that patients taking NOACs experienced a slower decline in cognitive function than those using warfarin or no blood thinners. The effect was modest each year but could add up over time.
  41. Scientists are testing a counterintuitive way to fight mesothelioma, an aggressive asbestos-linked cancer with few effective treatments. A new experimental mesothelioma drug kills cancer cells by disabling PRX3, an antioxidant defense that tumors use to survive intense oxidative stress. In an early clinical trial, it controlled disease progression in 67% of patients and produced encouraging survival results, raising hopes that the strategy could eventually be used against other cancers.
  42. A wearable device has revealed nighttime hormone surges that may expose a frequently missed cause of high blood pressure. The discovery could help explain why primary aldosteronism often escapes standard blood tests and point toward a more accurate way to diagnose it.
  43. AI analysis of 400,000 Reddit posts found that users of drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound reported unexpected symptoms including menstrual changes, chills, hot flashes, and fatigue. Researchers cannot say the medications caused these problems, but the patterns may reveal overlooked signals worth studying.
  44. Scientists have uncovered a natural braking system that helps the immune system switch off inflammation and prevent harmful immune cells from building up. Boosting this pathway in people reduced inflammation-related immune changes and sped up pain relief, pointing toward potential new treatments for chronic inflammatory diseases.
  45. Scientists discovered that aging cells can use malfunctioning mitochondria to unlock inflammatory genes and keep the immune system stuck in a prolonged state of alert. Blocking one part of this process reduced inflammation and improved healthy aging in mice, suggesting a promising new strategy for fighting age-related decline.
  46. GLP-1 drugs such as Ozempic, Wegovy, and Zepbound may increase hair-loss risk by 7% in men who are already genetically susceptible to male-pattern baldness. The findings suggest thinning hair may not be caused only by rapid weight loss and could also reflect a biological link between GLP-1 activity and hair follicles.
  47. A major Ontario study found 24 common medication chains in which one drug’s side effects can be mistaken for a new medical problem, leading to another prescription. Researchers say closer medication reviews, pharmacist involvement, and automated alerts could help prevent these potentially harmful prescribing cascades.
  48. People who drank at least one sugar-sweetened beverage a day had roughly 2.45 times the risk of gastric cancer compared with those who rarely consumed them, according to a decades-long study of more than 112,000 U.S. adults. Artificially sweetened drinks showed no similar association, though researchers stress that the findings do not prove sugary beverages cause cancer.
  49. Researchers discovered that combinations of toxin-blocking proteins naturally found in rattlesnake blood can powerfully neutralize venom from several dangerous snake species. In lab tests, the mixtures were about 10 times more potent than a current commercial antivenom, pointing toward a new generation of nature-inspired snakebite treatments.
  50. A large study of nearly 74,000 men suggests that long-term use of tadalafil, best known as Cialis, may be linked to a higher risk of glaucoma and other eye pressure problems. Men prescribed the drug for urinary symptoms caused by an enlarged prostate were 22% more likely to develop glaucoma, 32% more likely to develop ocular hypertension, and 33% more likely to be diagnosed with primary open-angle glaucoma or start glaucoma treatment over five years.
  51. Starting statins soon after a type 2 diabetes diagnosis may do more than protect the heart. In a nationwide Danish study of more than 132,000 people, those who began statin treatment within a year of diagnosis had a 15% lower relative risk of developing dementia over 10 years compared with those who did not start statins.
  52. People with chronic insomnia who used melatonin long term had a roughly 90% higher risk of developing heart failure over five years, according to a large preliminary study. The findings do not prove melatonin causes heart problems, but they raise new questions about the safety of taking the popular sleep supplement for extended periods.
  53. Omega-3 and low-dose aspirin matched the effectiveness of antibiotics in a year-long study of patients with severe gum disease, with both approaches helping about 58% reach the treatment goal. The unexpected result could point to a new way to treat some patients while reducing reliance on antibiotics and the growing problem of antibiotic resistance.
  54. CAR T-cell therapy dramatically reduced disease activity in six people with severe rheumatoid arthritis that had resisted other treatments, with three achieving medication-free remission. The treatment may work by clearing out harmful immune cells and effectively rebooting part of the immune system, although much larger studies are still needed.
  55. Common medications may reshape the gut microbiome long after the last dose is taken. In a study of more than 2,500 people, researchers found lasting microbial changes linked not only to antibiotics, but also to antidepressants, beta-blockers, acid-reducing drugs, and benzodiazepines. Some effects were still detectable years later, suggesting past medication use may strongly influence the gut bacteria people carry today.
  56. Gut bacteria can transform nitrate and plant-based iron from vegetables and other foods into protective molecules that may benefit the heart and metabolism. In experimental models, higher levels of these compounds were linked to lower blood pressure, better blood sugar control, healthier blood vessels, and less liver fat.
  57. A simple yeast-based food supplement may help restore the immune system’s ability to fight cancer, according to new research in mice. Scientists found that yeast beta-glucan reprogrammed early immune cells in the bone marrow, leading to stronger, longer-lasting cancer-fighting responses against colorectal, skin, and breast cancer cells.
  58. A hormone already known for curbing appetite and supporting weight loss may have a surprising second job: protecting the liver from inflammation and scarring. Researchers at McMaster University found that GDF15 activates a previously unknown brain-to-liver pathway that triggers the release of glucocorticoids, helping calm immune activity in the liver.
  59. A compound made when gut bacteria break down dietary fiber may do more than briefly calm inflammation—it could leave a lasting protective “memory” in the gut. Northwestern Medicine researchers found that butyrate can reprogram intestinal lining cells so they continue encouraging anti-inflammatory immune responses even after the compound is gone. In mice, this effect boosted production of the immune-calming molecule IL-10 and reduced the severity of colitis-like disease.
  60. Engineered probiotic bacteria were able to infiltrate pancreatic tumors, stimulate cancer-fighting immune cells, and slow tumor growth in animal studies. Even more strikingly, the treatment worked better when combined with chemotherapy, radiation, or immunotherapy.